Items 1 to 10 of about 363753
1. Dudareva-Vizule S, Haar K, Sailer A, Jansen K, Hamouda O, Wisplinghoff H, Tiemann C, Pape E, Bremer V, Chlamydia trachomatis laboratory sentinel team: Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014. Euro Surveill; 2017 Feb 09;22(6)
MedlinePlus Health Information. consumer health - Chlamydia Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Establishment of a voluntary electronic Chlamydia trachomatis laboratory surveillance system in Germany, 2008 to 2014.
  • In the period from 2008 to 2014, 3,877,588 CT tests were reported, 93% in women.
  • Women aged 20-24 years and men aged 25-29 years were the most frequently tested age groups.
  • The overall proportion of positive tests (PPT) among women was 3.9% and among men 11.0%.
  • The highest PPT among women was in the age groups 15-19 (6.8%) and 20-24 years (5.9%), and among men in the age groups 20-24 (19.2%), 15-19 (15.4%) and 25-29 years (14.8%).

  • Genetic Alliance. consumer health - Chlamydia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] This article is copyright of The Authors, 2017.
  • [Cites] Obstet Gynecol. 1998 Aug;92(2):292-8 [9699769.001]
  • [Cites] Euro Surveill. 2015;20(36):null [26535784.001]
  • [Cites] Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Dec;56(12):1600-8 [24337121.001]
  • [Cites] J Dtsch Dermatol Ges. 2008 Dec;6(12):1032-7 [18479502.001]
  • [Cites] PLoS One. 2011;6(10):e25691 [21991334.001]
  • [Cites] Hautarzt. 2007 Jan;58(1):18-23 [17165067.001]
  • [Cites] Sex Health. 2011 Mar;8(1):120-2 [21371394.001]
  • [Cites] Sex Transm Dis. 1997 Mar;24(3):131-41 [9132979.001]
  • [Cites] BMJ. 2012 Jul 05;345:e4316 [22767614.001]
  • [Cites] Sex Transm Dis. 1999 Oct;26(9):519-26 [10534206.001]
  • [Cites] Gesundheitswesen. 2014 Oct;76(10):e44-50 [24203685.001]
  • [Cites] Sex Transm Infect. 2005 Apr;81(2):173-9 [15800099.001]
  • [Cites] Euro Surveill. 2013 Aug 22;18(34):null [23987832.001]
  • [Cites] Sex Transm Infect. 2010 Aug;86(4):263-70 [20660590.001]
  • [Cites] Sex Transm Infect. 2013 Dec;89(8):672-8 [24005255.001]
  • [Cites] Arch Sex Behav. 2015 Apr;44(3):531-69 [25425161.001]
  • [Cites] N Engl J Med. 1996 May 23;334(21):1362-6 [8614421.001]
  • [Cites] Sex Transm Infect. 2004 Aug;80(4):255-63 [15295121.001]
  • [Cites] Sex Transm Dis. 1996 Sep-Oct;23(5):384-91 [8885069.001]
  • [Cites] Emerg Infect Dis. 2011 Sep;17(9):1630-5 [21888787.001]
  • [Cites] Lancet. 2001 Dec 1;358(9296):1851-4 [11741624.001]
  • [Cites] Sex Transm Infect. 2014 Feb;90(1):46-51 [23920398.001]
  • [Cites] Sex Transm Infect. 2004 Apr;80(2):121-3 [15054174.001]
  • (PMID = 28205505.001).
  • [ISSN] 1560-7917
  • [Journal-full-title] Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • [ISO-abbreviation] Euro Surveill.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  • [Keywords] NOTNLM ; Chlamydia trachomatis / Germany / laboratory surveillance / screening / sentinel / sexually transmitted infections / surveillance
  •  go-up   go-down


2. Pärna K, Põld M, Ringmets I: Trends in smoking behaviour among Estonian physicians in 1982-2014. BMC Public Health; 2017 Jul 25;18(1):55

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trends in smoking behaviour among Estonian physicians in 1982-2014.
  • The aim of this study was to give an overview of smoking behaviour among Estonian physicians from 1982 to 2014.
  • The number of physicians participating in this study was 3786 in 1982, 2735 in 2002, and 2902 in 2014.
  • RESULTS: Age-standardized prevalence of current smoking among men was 39.7% in 1982, 20.9% in 2002, and 14.3% in 2014 and among women 12.2%, 8.0%, and 5.2%, respectively (p < 0.0001 for trends).
  • From 1982 to 2014, the biggest decline of current smoking among men and women was in age groups under 35 (from 55.2% to 16.7% and from 16.7% to 2.8%, respectively) and 35-44 (from 47.1% to 8.3% and from 19.5% to 5.1%, respectively) (p < 0.0001 for trends).
  • Mean age of smoking initiation decreased from 20.4 to 19.3 among men and from 24.5 to 20.4 among women over the study period.
  • CONCLUSIONS: In 1982-2014, smoking prevalence among Estonian physicians declined substantially.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Public Health. 2007 Jun 20;7:115 [17578582.001]
  • [Cites] JAMA. 1994 Apr 27;271(16):1273-5 [8151902.001]
  • [Cites] CA Cancer J Clin. 1976 Nov-Dec;26(6):373-75 [825202.001]
  • [Cites] Tob Induc Dis. 2008 Dec 29;4:13 [19114012.001]
  • [Cites] JAMA. 2001 May 23-30;285(20):2643-8 [11368741.001]
  • [Cites] J Epidemiol. 2013;23(1):4-11 [23149752.001]
  • [Cites] Scand J Public Health. 2002;30(2):133-40 [12028862.001]
  • [Cites] Public Health. 1998 Jan;112(1):57-62 [9490891.001]
  • [Cites] N Engl J Med. 1991 Sep 26;325(13):968-9 [1881424.001]
  • [Cites] Eur J Public Health. 2005 Feb;15(1):33-8 [15788801.001]
  • [Cites] Tob Induc Dis. 2008 Sep 09;4:9 [18822167.001]
  • [Cites] J Epidemiol Community Health. 2000 Apr;54(4):320 [10827918.001]
  • [Cites] Stat Med. 1985 Jan-Mar;4(1):87-90 [3992076.001]
  • [Cites] BMJ. 1994 Oct 8;309(6959):901-11 [7755693.001]
  • [Cites] Eur J Public Health. 2004 Jun;14(2):201-3 [15230511.001]
  • [Cites] Drug Alcohol Depend. 1993 Sep;33(2):129-37 [8261877.001]
  • [Cites] Intern Med. 1997 Mar;36(3):162-5 [9144005.001]
  • [Cites] BMC Public Health. 2012 Nov 24;12:1028 [23176746.001]
  • [Cites] Public Health. 2005 May;119(5):390-9 [15780327.001]
  • [Cites] Soz Praventivmed. 2005;50(6):378-88 [16398100.001]
  • [ErratumIn] BMC Public Health. 2017 Sep 22;17 (1):736 [28938882.001]
  • (PMID = 28743258.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Estonia / Physicians / Smoking / Trends
  •  go-up   go-down


3. Nimpa Mengouo M, Ndze VN, Baonga F, Kobela M, Wiysonge CS: Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008-2014. BMJ Open; 2017 Apr 07;7(4):e012959

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008-2014.
  • DESIGN: This was a cross-sectional study for rubella infection in Cameroon for the period 2008 to 2014.
  • RESULTS: A total of 9907 serum samples from people with fever and rash were received in the laboratory from 2008 to 2014.
  • Logistic regression analysis revealed that, comparing the proportion of rubella IgM seropositivity status by age, the association to a positive rubella IgM increased with age from 1 to 4 years (OR 7.11; 95% CI 4.35 to 12.41; p<0.0001), through 5 to 9 years (OR 13.07; 95% CI 7.93 to 22.93; p<0.001), to 10 to 14 years of age (OR 13.86; 95% CI 8.06 to 25.12; p<0.001).
  • No statistically significant difference in proportion of rubella cases was observed between urban and rural populations (OR 1.11; 95% CI 0.94 to 1.31; p=0.208).
  • CONCLUSIONS: This study reveals that rubella virus circulates in Cameroon, with important number of cases in children under 15 years.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
  • [Cites] BMC Pregnancy Childbirth. 2014 Mar 03;14:95 [24589180.001]
  • [Cites] Afr J Reprod Health. 2009 Jun;13(2):69-73 [20690250.001]
  • [Cites] Niger J Clin Pract. 2011 Apr-Jun;14(2):140-5 [21860127.001]
  • [Cites] J Infect Dis. 2011 Jul;204 Suppl 1:S491-8 [21666205.001]
  • [Cites] BMC Public Health. 2015 Mar 27;15:294 [25885586.001]
  • [Cites] Virol J. 2011 May 19;8:244 [21595973.001]
  • [Cites] Bull World Health Organ. 1997;75(1):69-80 [9141752.001]
  • [Cites] J Infect Dis. 2011 Jul;204 Suppl 1:S239-42 [21666167.001]
  • [Cites] West Afr J Med. 2004 Jul-Sep;23(3):245-8 [15587839.001]
  • [Cites] N Engl J Med. 1965 Dec 16;273(25):1362-6 [5892083.001]
  • [Cites] BMC Public Health. 2013 Apr 29;13:406 [23627715.001]
  • [Cites] JAMA. 1965 May 24;192:675-81 [14280514.001]
  • (PMID = 28389483.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cameroon / Rubella / Surveillance
  •  go-up   go-down


4. Boudon SM, Vuorinen A, Geotti-Bianchini P, Wandeler E, Kratschmar DV, Heidl M, Campiche R, Jackson E, Odermatt A: Novel 11β-hydroxysteroid dehydrogenase 1 inhibitors reduce cortisol levels in keratinocytes and improve dermal collagen content in human ex vivo skin after exposure to cortisone and UV. PLoS One; 2017;12(2):e0171079
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] 11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors. Collagen / metabolism. Hydrocortisone / metabolism. Keratinocytes / drug effects. Keratinocytes / metabolism. Skin / drug effects. Skin / metabolism

  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Chem. 2014 Jul 24;57(14):5995-6007 [24960438.001]
  • [Cites] Nucleic Acids Res. 2000 Jan 1;28(1):235-42 [10592235.001]
  • [Cites] Drug Metab Rev. 2012 May;44(2):173-91 [22181347.001]
  • [Cites] Endocr Rev. 2013 Dec;34(6):827-84 [23939821.001]
  • [Cites] J Invest Dermatol. 2015 Jun;135(6):1638-48 [25317845.001]
  • [Cites] PLoS One. 2014 Mar 25;9(3):e93051 [24667799.001]
  • [Cites] J Endocrinol. 2003 Sep;178(3):331-7 [12967326.001]
  • [Cites] Mol Cell Endocrinol. 2012 Mar 24;350(2):168-86 [21820034.001]
  • [Cites] J Invest Dermatol. 2007 Dec;127(12):2749-58 [17657244.001]
  • [Cites] J Cell Biochem. 2011 Jun;112(6):1499-505 [21344493.001]
  • [Cites] J Invest Dermatol. 2011 Jan;131(1):30-6 [20739946.001]
  • [Cites] Br J Dermatol. 2013 Mar;168(3):595-601 [23363016.001]
  • [Cites] J Neuroinflammation. 2012 Nov 28;9:260 [23190711.001]
  • [Cites] Horm Res. 2000;54(5-6):218-29 [11595810.001]
  • [Cites] Br J Dermatol. 2002 Nov;147(5):859-68 [12410694.001]
  • [Cites] J Clin Invest. 2013 Jul;123(7):3051-60 [23722901.001]
  • [Cites] Endocr Rev. 2004 Oct;25(5):831-66 [15466942.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E701-6 [15572653.001]
  • [Cites] J Clin Endocrinol Metab. 1996 Jul;81(7):2746-9 [8675607.001]
  • [Cites] Mol Cell Endocrinol. 2003 Dec 30;212(1-2):41-9 [14654249.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2011 Sep;301(3):E484-93 [21673307.001]
  • [Cites] J Photochem Photobiol B. 1989 Oct;4(1):1-13 [2509656.001]
  • [Cites] J Neuroimmunol. 2005 May;162(1-2):97-102 [15833364.001]
  • [Cites] J Steroid Biochem Mol Biol. 2013 Sep;137:107-23 [23435015.001]
  • [Cites] Fitoterapia. 2009 Apr;80(3):200-5 [19535018.001]
  • [Cites] Skin Pharmacol Appl Skin Physiol. 2002 Mar-Apr;15(2):85-91 [11867964.001]
  • [Cites] J Invest Dermatol. 1979 Jul;73(1):59-66 [448178.001]
  • [Cites] J Med Chem. 2002 Aug 29;45(18):3813-5 [12190302.001]
  • [Cites] Clin Sci (Lond). 1998 Jun;94(6):557-72 [9854452.001]
  • [Cites] J Med Chem. 2014 Jun 12;57(11):4466-86 [24294985.001]
  • [Cites] FEBS J. 2010 May;277(10):2375-86 [20423462.001]
  • [Cites] J Invest Dermatol. 1991 Apr;96(4):484-9 [2007786.001]
  • [Cites] Exp Dermatol. 2010 Aug;19(8):757-9 [20659158.001]
  • [Cites] Mol Carcinog. 2007 Aug;46(8):732-40 [17538956.001]
  • [Cites] PLoS One. 2011;6(9):e25039 [21949844.001]
  • [Cites] Bioorg Med Chem. 2012 Feb 15;20(4):1557-68 [22285569.001]
  • [Cites] FEBS Lett. 2004 Sep 10;574(1-3):167-70 [15358559.001]
  • [Cites] Arch Dermatol Res. 1998 Jul;290(7):388-93 [9749994.001]
  • [Cites] Skin Pharmacol. 1997;10(5-6):261-4 [9449164.001]
  • [Cites] J Biol Chem. 2007 Feb 9;282(6):4021-34 [17095510.001]
  • [Cites] Curr Top Med Chem. 2011;11(12):1464-75 [21510838.001]
  • [Cites] Am J Pathol. 2006 Jun;168(6):1861-8 [16723701.001]
  • [Cites] Mol Cell Endocrinol. 2007 Sep 15;275(1-2):71-8 [17630118.001]
  • [Cites] Pigment Cell Res. 2006 Dec;19(6):606-14 [17083487.001]
  • [Cites] Photochem Photobiol Sci. 2013 Jan;12(1):54-64 [23111621.001]
  • [Cites] Arch Dermatol Res. 2010 Jan;302(1):5-17 [19756672.001]
  • [Cites] J Invest Dermatol. 1992 Feb;98(2):220-5 [1732386.001]
  • (PMID = 28152550.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Amides; 0 / Enzyme Inhibitors; 9007-34-5 / Collagen; EC 1.1.1.146 / 11-beta-Hydroxysteroid Dehydrogenase Type 1; EC 1.1.1.146 / HSD11B1 protein, human; V27W9254FZ / Cortisone; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


5. Hamner HC, Perrine CG, Gupta PM, Herrick KA, Cogswell ME: Food Consumption Patterns among U.S. Children from Birth to 23 Months of Age, 2009-2014. Nutrients; 2017 Aug 26;9(9)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Food Consumption Patterns among U.S. Children from Birth to 23 Months of Age, 2009-2014.
  • This study describes food consumption patterns among US children ≤23 months.
  • We used one 24 h dietary recall from the National Health and Nutrition Examination Survey 2009-2014 to estimate the percentage of children ≤23 months who consumed selected food/beverage categories on any given day by age and race/Hispanic origin.
  • Among 0 to 5 month olds, 42.9% (95% Confidence Interval (CI): 37.0%, 49.1%) consumed breast milk, with non-Hispanic blacks less likely (21.2%, 95% CI: 13.2%, 32.2%) compared with non-Hispanic whites (49.0%, 95% CI: 39.0%, 59.1%) (<i>p</i> < 0.001).
  • The percentage of children consuming vegetables was 57.4%, 48.2%, and 45.1% for ages 6 to 11, 12 to 18 and 19 to 23 months, respectively (<i>p</i> < 0.01 for trend).
  • The percentage of children consuming sugar-sweetened beverages was 6.6%, 31.8% and 38.3% for ages 6 to 11, 12 to 18 and 19 to 23 months, respectively (<i>p</i> < 0.01 for trend).
  • Among children aged ≥6 months, lower percentages of non-Hispanic black and Hispanic children consumed vegetables, and higher percentages consumed sugar-sweetened beverages and 100% juice compared with non-Hispanic white children, although differences were not always statistically significant.
  • Compared with children in the second year of life, a higher percentage of children 6 to 11 months of age consumed vegetables and a lower percentage consumed 100% juice, sugar-sweetened beverages, snacks, or sweets; with differences by race/Hispanic origin.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Diet Assoc. 2010 Dec;110(12 Suppl):S16-26 [21092765.001]
  • [Cites] Vital Health Stat 2. 2013 Aug;(160):1-23 [25090039.001]
  • [Cites] J Am Diet Assoc. 2010 Dec;110(12 Suppl):S38-51 [21092767.001]
  • [Cites] Am J Clin Nutr. 2014 Mar;99(3):723S-8S [24452235.001]
  • [Cites] Am J Clin Nutr. 2009 Mar;89(3):897-904 [19144728.001]
  • [Cites] Pediatrics. 2014 Sep;134 Suppl 1:S56-62 [25183757.001]
  • [Cites] Vital Health Stat 2. 2013 Sep;(161):1-24 [25090154.001]
  • [Cites] Am J Clin Nutr. 2008 Aug;88(2):324-32 [18689367.001]
  • [Cites] Pediatrics. 2008 Oct;122 Suppl 2:S36-42 [18829829.001]
  • [Cites] J Am Diet Assoc. 2006 Jan;106(1 Suppl 1):S96-106 [16376634.001]
  • [Cites] Child Obes. 2014 Oct;10 (5):408-15 [25259675.001]
  • [Cites] Am J Clin Nutr. 2014 Mar;99(3):663S-91S [24500158.001]
  • [Cites] J Am Diet Assoc. 2010 Oct;110(10):1501-10 [20869489.001]
  • [Cites] Vital Health Stat 2. 2014 Mar;(162):1-33 [25569458.001]
  • [Cites] J Am Diet Assoc. 2010 Sep;110(9):1335-9 [20800125.001]
  • [Cites] J Am Diet Assoc. 2006 Jan;106(1 Suppl 1):S107-23 [16376635.001]
  • [Cites] Pediatrics. 2014 Sep;134 Suppl 1:S50-5 [25183756.001]
  • [Cites] J Nutr. 2015 Dec;145(12 ):2639-45 [26468491.001]
  • [Cites] Adv Nutr. 2016 Jan 15;7(1):211S-219S [26773029.001]
  • (PMID = 28846605.001).
  • [ISSN] 2072-6643
  • [Journal-full-title] Nutrients
  • [ISO-abbreviation] Nutrients
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; NHANES / food consumption patterns / fruit and vegetables / race/Hispanic origin / sugar-sweetened beverages / young children
  •  go-up   go-down


6. Bergland A, Jørgensen L, Emaus N, Strand BH: Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Tromsø study. BMC Health Serv Res; 2017 Jan 10;17(1):22

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mobility as a predictor of all-cause mortality in older men and women: 11.8 year follow-up in the Tromsø study.
  • Participants were linked to the Cause of Death Registry and followed up for mortality for a maximum of 11.8 years.
  • Compared to the quickest fifth, the slowest fifth had hazard ratio (HR) of 1.79 (95% confidence interval (CI) 1.33, 2.42) in a model adjusted for age and gender.
  • For each standard deviation TUG-score the increase in HR was 1.23 (95% CI 1.14, 1.33).
  • The association between the TUG score and mortality remained significant after adjusting for self-reported health, body mass index, smoking and education.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Geriatr Soc. 2007 Oct;55(10):1598-603 [17908062.001]
  • [Cites] J Nutr Health Aging. 2009 Dec;13(10):881-9 [19924348.001]
  • [Cites] Age Ageing. 2000 May;29(3):235-42 [10855906.001]
  • [Cites] Am J Public Health. 2005 Nov;95(11):2029-34 [16195527.001]
  • [Cites] J Am Geriatr Soc. 2010 Sep;58(9):1686-92 [20863328.001]
  • [Cites] Can Fam Physician. 2001 Jun;47:1205-7 [11421048.001]
  • [Cites] Int J Audiol. 2008 Feb;47(2):67-75 [18236239.001]
  • [Cites] J Clin Oncol. 2012 May 20;30(15):1829-34 [22508806.001]
  • [Cites] J Am Soc Nephrol. 2013 Apr;24(5):822-30 [23599380.001]
  • [Cites] Am J Epidemiol. 1993 Apr 15;137(8):845-57 [8484376.001]
  • [Cites] Age Ageing. 2006 Jul;35(4):382-7 [16638760.001]
  • [Cites] J Nutr Health Aging. 2009 Dec;13(10):878-80 [19924347.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1380-8 [19126852.001]
  • [Cites] Health Aff (Millwood). 2001 Nov-Dec;20(6):146-60 [11816653.001]
  • [Cites] Age Ageing. 1995 Jul;24(4):292-6 [7484485.001]
  • [Cites] J Clin Epidemiol. 2003 Aug;56(8):807-13 [12954475.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63 [15031310.001]
  • [Cites] Geriatr Nurs. 2001 Sep-Oct;22(5):258-62 [11606904.001]
  • [Cites] Dement Geriatr Cogn Dis Extra. 2016 Sep 10;6(3):396-406 [27703472.001]
  • [Cites] Eur J Clin Invest. 2013 Apr;43(4):379-86 [23398295.001]
  • [Cites] Scand J Public Health. 2013 Feb;41(1):102-8 [23178925.001]
  • [Cites] Am J Kidney Dis. 2008 Mar;51(3):395-406 [18295055.001]
  • [Cites] Arch Gerontol Geriatr. 2011 Jul-Aug;53(1):79-83 [20678816.001]
  • [Cites] Neuroepidemiology. 2006;26(1):52-60 [16254454.001]
  • [Cites] Popul Health Manag. 2011 Feb;14 Suppl 1:S35-44 [21323619.001]
  • [Cites] Arch Phys Med Rehabil. 2010 Feb;91(2):241-6 [20159128.001]
  • [Cites] J Gerontol. 1994 Sep;49(5):S240-52 [8056953.001]
  • [Cites] BMC Med Res Methodol. 2012 Sep 14;12:143 [22978749.001]
  • [Cites] J Gerontol. 1994 Mar;49(2):M85-94 [8126356.001]
  • [Cites] Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):1-4 [19945178.001]
  • [Cites] Ann Intern Med. 2012 Jan 17;156(2):131-40 [22250144.001]
  • [Cites] Qual Health Res. 2003 Feb;13(2):207-26 [12643029.001]
  • [Cites] J Am Geriatr Soc. 2010 May;58(5):844-52 [20406319.001]
  • [Cites] Soc Sci Med. 2003 Jun;56(12):2493-503 [12742612.001]
  • [Cites] Age Ageing. 2013 Jul;42(4):468-75 [23486170.001]
  • [Cites] Arch Phys Med Rehabil. 2007 Sep;88(9):1108-13 [17826454.001]
  • [Cites] J Gen Intern Med. 2011 Feb;26(2):130-5 [20972641.001]
  • [Cites] J Am Geriatr Soc. 2000 Dec;48(12):1618-25 [11129752.001]
  • [Cites] BMC Geriatr. 2014 Feb 01;14:14 [24484314.001]
  • [Cites] Physiother Res Int. 2007 Jun;12(2):72-81 [17536645.001]
  • [Cites] J Aging Phys Act. 2016 Jan;24(1):92-100 [26098078.001]
  • [Cites] J Am Geriatr Soc. 1991 Feb;39(2):142-8 [1991946.001]
  • [Cites] J Am Geriatr Soc. 2011 May;59(5):887-92 [21410448.001]
  • [Cites] Age Ageing. 2003 May;32(3):315-20 [12720619.001]
  • [Cites] J Rehabil Med. 2003 Mar;35(2):76-83 [12691337.001]
  • [Cites] J Am Geriatr Soc. 2001 May;49(5):664-72 [11380764.001]
  • [Cites] J Am Geriatr Soc. 2012 Sep;60(9):1681-6 [22985141.001]
  • [Cites] Neuroepidemiology. 2007;29(3-4):193-200 [18043004.001]
  • [Cites] J Gerontol. 1989 Sep;44(5):M141-6 [2768767.001]
  • [Cites] Annu Rev Public Health. 1996;17:25-46 [8724214.001]
  • [Cites] Vital Health Stat 3. 1993 Jan;(27):143-85 [8465257.001]
  • [Cites] Int J Epidemiol. 2012 Aug;41(4):961-7 [21422063.001]
  • [Cites] J Clin Epidemiol. 2004 May;57(5):513-21 [15196622.001]
  • [Cites] J Am Geriatr Soc. 2004 Aug;52(8):1343-8 [15271124.001]
  • [Cites] Arch Intern Med. 2006 Dec 11-25;166(22):2469-77 [17159012.001]
  • [Cites] J Clin Epidemiol. 1997 Mar;50(3):291-6 [9120528.001]
  • [Cites] Ann Surg. 2013 Oct;258(4):582-8; discussion 588-90 [23979272.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):324-33 [15860469.001]
  • [Cites] J Nutr Health Aging. 2010 Aug;14(7):595-600 [20818476.001]
  • [Cites] JAMA. 1998 Feb 25;279(8):585-92 [9486752.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):441-6 [22987796.001]
  • [Cites] J Gerontol B Psychol Sci Soc Sci. 1997 May;52(3):S155-63 [9158572.001]
  • [Cites] J Aging Health. 1998 Nov;10(4):422-40 [10346693.001]
  • [Cites] J Am Geriatr Soc. 2007 Oct;55(10):1618-23 [17697103.001]
  • [Cites] J Geriatr Phys Ther. 2006;29(2):64-8 [16914068.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2008 Jun;63(6):586-7 [18559632.001]
  • [Cites] J Geriatr Phys Ther. 2008;31(2):57-63 [19856551.001]
  • [Cites] Isokinet Exerc Sci. 2011;19(2):null [24339479.001]
  • [Cites] J Am Geriatr Soc. 2013 Feb;61(2):202-8 [23350947.001]
  • [Cites] BMC Geriatr. 2007 Jan 12;7:1 [17222340.001]
  • [Cites] Phys Ther. 2002 Feb;82(2):128-37 [11856064.001]
  • [Cites] Hypertens Res. 2008 Jul;31(7):1331-8 [18957803.001]
  • [Cites] J Clin Epidemiol. 2003 Dec;56(12):1192-201 [14680670.001]
  • (PMID = 28068995.001).
  • [ISSN] 1472-6963
  • [Journal-full-title] BMC health services research
  • [ISO-abbreviation] BMC Health Serv Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Mobility / Mortality / Predictors / Self-rated health
  •  go-up   go-down


7. Undurraga EA, Meltzer MI, Tran CH, Atkins CY, Etheart MD, Millien MF, Adrien P, Wallace RM: Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015. Am J Trop Med Hyg; 2017 Jun;96(6):1307-1317
MedlinePlus Health Information. consumer health - Rabies.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cost-Effectiveness Evaluation of a Novel Integrated Bite Case Management Program for the Control of Human Rabies, Haiti 2014-2015.
  • Our evaluation encompassed all individuals exposed to rabies in the study area (<i>N</i> = 2,289) in 2014-2015.
  • Costs (2014 U.S. dollars) included diagnostic laboratory development, training of surveillance officers, operational costs, and postexposure prophylaxis (PEP).
  • HARSP had higher overall costs (range: $39,568-$80,290) than the no-bite-case-management (NBCM) scenario ($15,988-$26,976), partly from an increased number of bite victims receiving PEP.
  • But HARSP had better health outcomes than NBCM, with estimated 11 additional annual averted deaths in 2014 and nine in 2015, and 654 additional YLG in 2014 and 535 in 2015.
  • Overall, HARSP was more cost-effective (US$ per death averted) than NBCM (2014, HARSP: $2,891-$4,735, NBCM: $5,980-$8,453; 2015, HARSP: $3,534-$7,171, NBCM: $7,298-$12,284).

  • Genetic Alliance. consumer health - Rabies.
  • MedlinePlus Health Information. consumer health - Animal Bites.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bull World Health Organ. 1993;71(5):615-24 [8261565.001]
  • [Cites] Emerg Infect Dis. 2013 Apr;19(4):678-9 [23750499.001]
  • [Cites] Lancet Infect Dis. 2002 Jun;2(6):327-43 [12144896.001]
  • [Cites] Emerg Infect Dis. 2007 Jan;13(1):136-9 [17370529.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Nov 24;9(11):e0004245 [26600437.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003806 [26110845.001]
  • [Cites] PLoS Negl Trop Dis. 2010 Feb 23;4(2):e626 [20186330.001]
  • [Cites] Emerg Infect Dis. 2004 Jan;10(1):140-2 [15078611.001]
  • [Cites] PLoS Negl Trop Dis. 2008;2(11):e339 [19030223.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120143 [23798691.001]
  • [Cites] Transbound Emerg Dis. 2017 Jun;64(3):951-958 [26916104.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Feb 20;64(6):137-40 [25695317.001]
  • [Cites] Epidemiol Infect. 2017 Jun;145(8):1624-1634 [28290915.001]
  • [Cites] Vaccine. 2009 Nov 27;27(51):7167-72 [19925948.001]
  • [Cites] Virus Res. 2005 Jul;111(1):5-12 [15896398.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Apr 16;9(4):e0003709 [25881058.001]
  • [Cites] PLoS Biol. 2009 Mar 10;7(3):e53 [19278295.001]
  • [Cites] Bull World Health Organ. 2005 May;83(5):360-8 [15976877.001]
  • [Cites] Prev Vet Med. 2010 Oct 1;97(1):51-7 [20696487.001]
  • [Cites] Lancet. 2014 Oct 11;384(9951):1389-99 [24828901.001]
  • [Cites] Front Vet Sci. 2017 Feb 10;4:9 [28239608.001]
  • [Cites] Lancet. 2012 Dec 15;380(9859):2063-6 [23245602.001]
  • [Cites] Vaccine. 2002 Sep 10;20(27-28):3332-41 [12213403.001]
  • [Cites] Bull World Health Organ. 2002;80(4):304-10 [12075367.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Mar 08;5(3):e982 [21408121.001]
  • (PMID = 28719253.001).
  • [ISSN] 1476-1645
  • [Journal-full-title] The American journal of tropical medicine and hygiene
  • [ISO-abbreviation] Am. J. Trop. Med. Hyg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Rabies Vaccines
  •  go-up   go-down


8. Mace KE, Arguin PM: Malaria Surveillance - United States, 2014. MMWR Surveill Summ; 2017 May 26;66(12):1-24
MedlinePlus Health Information. consumer health - Malaria.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malaria Surveillance - United States, 2014.
  • PERIOD COVERED: This report summarizes cases in persons with onset of illness in 2014 and trends during previous years.
  • RESULTS: CDC received reports of 1,724 confirmed malaria cases, including one congenital case and two cryptic cases, with onset of symptoms in 2014 among persons in the United States.
  • The number of confirmed cases in 2014 is consistent with the number of confirmed cases reported in 2013 (n = 1,741; this number has been updated from a previous publication to account for delayed reporting for persons with symptom onset occurring in late 2013).
  • The infecting species was unreported or undetermined in 11.7% of cases.
  • CDC received 137 P. falciparum-positive samples for the detection of antimalarial resistance markers (although some loci for chloroquine and mefloquine were untestable for up to nine samples).
  • INTERPRETATION: The overall trend of malaria cases has been increasing since 1973; the number of cases reported in 2014 is the fourth highest annual total since then.
  • PUBLIC HEALTH ACTION: Completion of data elements on the malaria case report form increased slightly in 2014 compared with 2013, but still remains unacceptably low.
  • In 2014, at least one essential element (i.e., species, travel history, or resident status) was missing in 21.3% of case report forms.
  • Evidence-based prevention strategies that effectively target VFR travelers need to be developed and implemented to have a substantial impact on the number of imported malaria cases in the United States.
  • Fewer U.S. resident patients reported taking chemoprophylaxis in 2014 (27.2%) compared with 2013 (28.6%), and adherence was poor among those who did take chemoprophylaxis.

  • Genetic Alliance. consumer health - Malaria.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28542123.001).
  • [ISSN] 1545-8636
  • [Journal-full-title] Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002)
  • [ISO-abbreviation] MMWR Surveill Summ
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimalarials
  •  go-up   go-down


9. Neri L, Viglino G, Marinangeli G, Rocca AR, Laudon A, Ragusa A, Cabiddu G, Peritoneal Dialysis Study Group of Italian Society of Nephrology: Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014. J Nephrol; 2017 Aug;30(4):593-599

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014.
  • METHODS: By analyzing the peritoneal dialysis (PD) censuses conducted by the PD Study Group (GSDP-SIN) for the years 2005, 2008, 2010, 2012 and 2014 in all the Centers performing PD in Italy, the use of Incr-PD, i.e. continuous ambulatory peritoneal dialysis (CAPD) with 1 or 2 exchanges/day or automated peritoneal dialysis (APD) with 3-4 sessions/week, was examined among incident PD patients.
  • RESULTS: In 2014 PD was started in Italy by 1,652 patients, 455 (27.5%) of whom incrementally (Incr-CAPD 82.2% vs. Incr-APD 17.8%).
  • The number of patients and of Centers using Incr-DP increased constantly over the years up to 2012 (in 2005 Incr-PD was used in 33.4% of Centers, and in 11.9% of patients).
  • CONCLUSIONS: Incr-PD is used in Italy in a large number of incident PD patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] G Ital Nefrol. 2014 Jul-Aug;31(4):null [25098469.001]
  • [Cites] Kidney Int Suppl. 2008 Apr;(108):S52-5 [18379548.001]
  • [Cites] Kidney Int. 2003 Aug;64(2):649-56 [12846762.001]
  • [Cites] Perit Dial Int. 2012 Sep-Oct;32(5):558-65 [22383633.001]
  • [Cites] J Nephrol. 2016 Dec;29(6):871-879 [27582136.001]
  • [Cites] Perit Dial Int. 2000 Jul-Aug;20(4):418-22 [11007373.001]
  • [Cites] Am J Kidney Dis. 1997 Sep;30(3 Suppl 2):S67-136 [9293258.001]
  • [Cites] Am J Kidney Dis. 2000 Jul;36(1):105-14 [10873879.001]
  • [Cites] Kidney Int. 2002 Sep;62(3):1046-53 [12164889.001]
  • [Cites] Adv Perit Dial. 2003;19:93-6 [14763041.001]
  • [Cites] Nephrol Dial Transplant. 1995 Dec;10(12):2295-305 [8808229.001]
  • [Cites] Perit Dial Int. 2001 Sep-Oct;21(5):462-6 [11757829.001]
  • [Cites] J Am Soc Nephrol. 2002 May;13(5):1307-20 [11961019.001]
  • [Cites] J Nephrol. 2013 Nov-Dec;26 Suppl 21:96-119 [24307442.001]
  • [Cites] Indian J Nephrol. 2013 Jul;23(4):276-9 [23960344.001]
  • [Cites] Am J Kidney Dis. 2005 Sep;46(3):512-9 [16129214.001]
  • [Cites] Perit Dial Int. 2002 Jul-Aug;22(4):471-6 [12322818.001]
  • [Cites] Perit Dial Int. 2000 Jul-Aug;20(4):412-7 [11007372.001]
  • [Cites] J Am Soc Nephrol. 1996 Feb;7(2):198-207 [8785388.001]
  • [Cites] J Am Soc Nephrol. 2013 Sep;24(9):1367-70 [23868925.001]
  • [Cites] World J Nephrol. 2015 Nov 6;4(5):521-7 [26558189.001]
  • [Cites] J Nephrol. 2013 Nov-Dec;26 Suppl 21:83-95 [24307441.001]
  • (PMID = 28500518.001).
  • [ISSN] 1724-6059
  • [Journal-full-title] Journal of nephrology
  • [ISO-abbreviation] J. Nephrol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Keywords] NOTNLM ; Dialysis adequacy / Dialysis modality / Dialysis selection / Incremental dialysis / Peritoneal dialysis / Residual renal function
  •  go-up   go-down


10. Andrenyak DM, Moody DE, Slawson MH, O'Leary DS, Haney M: Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry. J Anal Toxicol; 2017 May 01;41(4):277-288
Hazardous Substances Data Bank. delta 9-Tetrahydrocannabinol .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
  • A gas chromatography-tandem mass spectrometry (GC-MS-MS) method was developed to test for CBD, THC, hydroxy-THC (OH-THC) and carboxy-THC (COOH-THC) in human plasma.
  • Matrix selectivity studies showed endogenous chromatographic peak area ratios (PAR) at the analyte retention times were <20% of the analyte limit of quantitation PAR.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
  • [Cites] Chem Biodivers. 2007 Aug;4(8):1770-804 [17712819.001]
  • [Cites] PLoS One. 2014 Dec 17;9(12):e113161 [25517414.001]
  • [Cites] Environ Toxicol Chem. 2001 Jan;20(1):133-9 [11351400.001]
  • [Cites] J Anal Toxicol. 2015 Oct;39(8):580-7 [26378131.001]
  • [Cites] J Mass Spectrom. 2004 May;39(5):526-31 [15170748.001]
  • [Cites] Biomed Mass Spectrom. 1983 May;10(5):316-23 [6305440.001]
  • [Cites] Forensic Sci Int. 2007 Aug 6;170(2-3):148-55 [17614225.001]
  • [Cites] J Anal Toxicol. 2009 Oct;33(8):469-77 [19874654.001]
  • [Cites] Clin Chem. 1987 Oct;33(11 Suppl):72B-81B [3315312.001]
  • [Cites] Int J Drug Policy. 2015 Jan;26(1):20-9 [25304050.001]
  • [Cites] J Anal Toxicol. 1986 Mar-Apr;10(2):56-64 [3009969.001]
  • [Cites] J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):178S-189S [6271823.001]
  • [Cites] Biomed Environ Mass Spectrom. 1986 Feb;13(2):77-83 [2937482.001]
  • [Cites] J Anal Toxicol. 1995 Sep;19(5):285-91 [7500614.001]
  • [Cites] Autoimmunity. 2006 Mar;39(2):143-51 [16698671.001]
  • [Cites] Pharmacotherapy. 2013 Feb;33(2):195-209 [23386598.001]
  • [Cites] J Neuroimmune Pharmacol. 2015 Jun;10(2):193-203 [26054900.001]
  • [Cites] Ther Drug Monit. 2014 Apr;36(2):218-24 [24067260.001]
  • [Cites] Clin Chem. 2013 Jul;59(7):1108-17 [23519966.001]
  • [Cites] J Anal Toxicol. 2008 Apr;32(3):208-19 [18397572.001]
  • [Cites] J Anal Toxicol. 2007 Apr;31(3):157-64 [17579963.001]
  • [Cites] Ther Drug Monit. 1993 Dec;15(6):557-62 [8122294.001]
  • [Cites] Pharmacol Rev. 1986 Mar;38(1):21-43 [3012605.001]
  • [Cites] J Anal Toxicol. 1992 Sep-Oct;16(5):276-82 [1338215.001]
  • [Cites] J Anal Toxicol. 1984 Sep-Oct;8(5):202-4 [6094914.001]
  • [Cites] Anal Bioanal Chem. 2014 Nov;406(29):7667-76 [25260412.001]
  • [Cites] Xenobiotica. 1990 Mar;20(3):303-20 [2336840.001]
  • [Cites] J Anal Toxicol. 2008 Jun;32(5):349-54 [18544220.001]
  • [Cites] JAMA. 2015 Jun 23-30;313(24):2456-73 [26103030.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Jun 5;772(2):239-48 [12007768.001]
  • [Cites] J Chromatogr A. 2005 Apr 1;1069(2):183-94 [15830944.001]
  • [Cites] Arch Gen Psychiatry. 2001 Apr;58(4):322-8 [11296091.001]
  • [Cites] Anal Bioanal Chem. 2010 May;397(2):603-11 [20306180.001]
  • [Cites] Clin Pharmacol Ther. 1983 Sep;34(3):352-63 [6309462.001]
  • [Cites] J Chromatogr A. 2007 Sep 7;1163(1-2):318-27 [17640656.001]
  • [Cites] J Anal Toxicol. 2013 Jul-Aug;37(6):337-44 [23743505.001]
  • [Cites] Clin Chem. 2011 Jan;57(1):66-75 [21078841.001]
  • [Cites] Psychopharmacology (Berl). 2007 Nov;194(4):505-15 [17619859.001]
  • [Cites] Clin Pharmacol Ther. 2015 Jun;97(6):587-96 [25669486.001]
  • [Cites] J Anal Toxicol. 2001 Oct;25(7):531-7 [11599596.001]
  • [Cites] Subst Abuse. 2015 May 21;9:33-8 [26056464.001]
  • [Cites] Neuropsychopharmacology. 2016 Jul;41(8):1974-82 [26708108.001]
  • [Cites] Forensic Sci Rev. 1990 Dec;2(2):147-57 [26266841.001]
  • [Cites] Biol Reprod. 1998 Jun;58(6):1490-5 [9623610.001]
  • [Cites] J Anal Toxicol. 1999 Oct;23(6):535-40 [10517563.001]
  • [Cites] J Nat Prod. 1980 Mar-Apr;43(2):169-234 [6991645.001]
  • [Cites] J Anal Toxicol. 2013 Sep;37(7):452-74 [23934984.001]
  • [Cites] J Anal Toxicol. 2005 Nov-Dec;29(8):782-9 [16356335.001]
  • [Cites] Anal Bioanal Chem. 2011 Sep;401(4):1273-83 [21727996.001]
  • [Cites] Ther Drug Monit. 1993 Dec;15(6):527-32 [8122288.001]
  • [Cites] J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Dec 5;798(1):145-54 [14630369.001]
  • [Cites] Science. 1972 Aug 18;177(4049):633-5 [4558903.001]
  • (PMID = 28069869.001).
  • [ISSN] 1945-2403
  • [Journal-full-title] Journal of analytical toxicology
  • [ISO-abbreviation] J Anal Toxicol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cannabinoids; 0 / Street Drugs; 19GBJ60SN5 / Cannabidiol; 7J8897W37S / Dronabinol
  •  go-up   go-down